MeiraGTx Holdings PLCNASDAQ:MGTX
- LAST PRICE6.2000
- TODAY'S CHANGE (%)0.2400 (4.0268%)
- Bid / Lots6.1900/ 8
- Ask / Lots6.2100/ 5
- Open / Previous Close5.9300 / 5.9600
- Day Range
- 52 Week Range
- Volume516,130
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MGTX |
|---|---|---|
| 09:32 ET | 1074 | 5.93 |
| 09:33 ET | 200 | 5.81 |
| 09:39 ET | 700 | 5.92 |
| 09:46 ET | 200 | 5.945 |
| 09:48 ET | 4700 | 5.9734 |
| 09:50 ET | 100 | 5.945 |
| 09:57 ET | 200 | 5.945 |
| 10:00 ET | 700 | 5.9253 |
| 10:02 ET | 899 | 5.97 |
| 10:04 ET | 300 | 6 |
| 10:06 ET | 200 | 6.03 |
| 10:08 ET | 2900 | 6.06 |
| 10:09 ET | 200 | 6.06 |
| 10:11 ET | 500 | 6.09 |
| 10:13 ET | 600 | 6.11 |
| 10:15 ET | 1926 | 6.11 |
| 10:18 ET | 1354 | 6.06 |
| 10:20 ET | 814 | 6.07 |
| 10:22 ET | 100 | 6.06 |
| 10:24 ET | 746 | 6.06 |
| 10:26 ET | 2365 | 6.05 |
| 10:27 ET | 200 | 6.05 |
| 10:29 ET | 300 | 6.05 |
| 10:31 ET | 256 | 6.065 |
| 10:33 ET | 438 | 6.06 |
| 10:36 ET | 730 | 6.05 |
| 10:38 ET | 7176 | 6.02 |
| 10:40 ET | 100 | 6.02 |
| 10:42 ET | 1900 | 6.06 |
| 10:44 ET | 300 | 6.055 |
| 10:45 ET | 2400 | 6.065 |
| 10:47 ET | 205 | 6.06 |
| 10:49 ET | 782 | 6.095 |
| 10:51 ET | 13800 | 6.1 |
| 10:54 ET | 452 | 6.09953 |
| 10:56 ET | 919 | 6.105 |
| 10:58 ET | 500 | 6.09 |
| 11:00 ET | 100 | 6.08 |
| 11:02 ET | 905 | 6.08 |
| 11:03 ET | 200 | 6.08 |
| 11:05 ET | 200 | 6.09 |
| 11:07 ET | 650 | 6.1 |
| 11:09 ET | 500 | 6.12 |
| 11:12 ET | 100 | 6.11 |
| 11:14 ET | 100 | 6.1093 |
| 11:16 ET | 200 | 6.14 |
| 11:18 ET | 100 | 6.14 |
| 11:20 ET | 3995 | 6.09 |
| 11:25 ET | 200 | 6.095 |
| 11:27 ET | 300 | 6.095 |
| 11:32 ET | 300 | 6.09 |
| 11:34 ET | 800 | 6.1 |
| 11:36 ET | 200 | 6.1 |
| 11:38 ET | 100 | 6.1 |
| 11:39 ET | 700 | 6.1 |
| 11:41 ET | 200 | 6.1 |
| 11:43 ET | 1000 | 6.08 |
| 11:45 ET | 422 | 6.0931 |
| 11:48 ET | 100 | 6.09 |
| 11:50 ET | 53890 | 6.1 |
| 11:54 ET | 800 | 6.12 |
| 11:56 ET | 500 | 6.11 |
| 11:57 ET | 100 | 6.12 |
| 11:59 ET | 1182 | 6.1 |
| 12:01 ET | 500 | 6.05 |
| 12:06 ET | 204 | 6.06 |
| 12:08 ET | 1300 | 6.015 |
| 12:10 ET | 400 | 5.99 |
| 12:14 ET | 3800 | 6.015 |
| 12:15 ET | 2200 | 6.03 |
| 12:17 ET | 200 | 6.035 |
| 12:19 ET | 369 | 6.04 |
| 12:21 ET | 100 | 6.04 |
| 12:24 ET | 300 | 6.03 |
| 12:26 ET | 600 | 6.04 |
| 12:28 ET | 100 | 6.04 |
| 12:30 ET | 826 | 6.04 |
| 12:32 ET | 100 | 6.04 |
| 12:33 ET | 713 | 6.035 |
| 12:35 ET | 1600 | 6.04 |
| 12:37 ET | 600 | 6.06 |
| 12:39 ET | 2766 | 6.06 |
| 12:42 ET | 713 | 6.06 |
| 12:46 ET | 100 | 6.05 |
| 12:48 ET | 500 | 6.06 |
| 12:50 ET | 200 | 6.05 |
| 12:51 ET | 1000 | 6.05 |
| 12:53 ET | 1699 | 6.05 |
| 12:55 ET | 1500 | 6.06 |
| 12:57 ET | 100 | 6.06 |
| 01:02 ET | 3609 | 6.02 |
| 01:08 ET | 200 | 6.02 |
| 01:11 ET | 100 | 6.04 |
| 01:13 ET | 200 | 6.03 |
| 01:15 ET | 500 | 6.04 |
| 01:18 ET | 400 | 6.05 |
| 01:20 ET | 100 | 6.06 |
| 01:22 ET | 100 | 6.06 |
| 01:24 ET | 100 | 6.06 |
| 01:26 ET | 200 | 6.05 |
| 01:27 ET | 600 | 6.06 |
| 01:29 ET | 300 | 6.06 |
| 01:31 ET | 400 | 6.05 |
| 01:33 ET | 993 | 6.04 |
| 01:36 ET | 300 | 6.03 |
| 01:38 ET | 100 | 6.025 |
| 01:42 ET | 100 | 6.02 |
| 01:44 ET | 2843 | 6.02 |
| 01:45 ET | 2528 | 6 |
| 01:47 ET | 200 | 5.995 |
| 01:49 ET | 2507 | 6.02 |
| 01:54 ET | 700 | 6.04 |
| 02:02 ET | 100 | 6.0697 |
| 02:03 ET | 2907 | 6.1 |
| 02:09 ET | 100 | 6.1 |
| 02:12 ET | 400 | 6.1 |
| 02:14 ET | 500 | 6.09 |
| 02:16 ET | 682 | 6.095 |
| 02:18 ET | 700 | 6.08 |
| 02:20 ET | 483 | 6.0793 |
| 02:21 ET | 200 | 6.07 |
| 02:23 ET | 100 | 6.08 |
| 02:25 ET | 355 | 6.0869 |
| 02:27 ET | 644 | 6.08 |
| 02:30 ET | 600 | 6.07 |
| 02:32 ET | 1158 | 6.06 |
| 02:34 ET | 1337 | 6.05 |
| 02:36 ET | 1859 | 6.08 |
| 02:38 ET | 790 | 6.07 |
| 02:41 ET | 100 | 6.09 |
| 02:43 ET | 200 | 6.08 |
| 02:45 ET | 100 | 6.08 |
| 02:48 ET | 200 | 6.08 |
| 02:50 ET | 400 | 6.08 |
| 02:52 ET | 300 | 6.08 |
| 02:54 ET | 722 | 6.085 |
| 02:56 ET | 702 | 6.09 |
| 02:57 ET | 781 | 6.085 |
| 02:59 ET | 836 | 6.08 |
| 03:01 ET | 600 | 6.075 |
| 03:03 ET | 830 | 6.09 |
| 03:06 ET | 5100 | 6.0899 |
| 03:08 ET | 200 | 6.09 |
| 03:10 ET | 1900 | 6.1 |
| 03:12 ET | 5488 | 6.12 |
| 03:14 ET | 709 | 6.125 |
| 03:15 ET | 50813 | 6.12 |
| 03:17 ET | 2219 | 6.09 |
| 03:19 ET | 100 | 6.1 |
| 03:21 ET | 500 | 6.1 |
| 03:24 ET | 1918 | 6.14 |
| 03:28 ET | 1500 | 6.15 |
| 03:30 ET | 400 | 6.14 |
| 03:32 ET | 757 | 6.14 |
| 03:33 ET | 201000 | 6.14 |
| 03:35 ET | 1626 | 6.14 |
| 03:37 ET | 6259 | 6.16 |
| 03:39 ET | 1562 | 6.185 |
| 03:42 ET | 400 | 6.185 |
| 03:44 ET | 2300 | 6.2 |
Oct 22, 2024
MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress, from 8:00AM ET on Tuesday Oct 22, 2024 by Dow Jones
8:00AM ET on Tuesday Oct 22, 2024 by Dow Jones
Oct 15, 2024
DJ MeiraGTx Shares Rise on Positive Data for Parkinson's Disease Treatment, from 8:15AM ET on Tuesday Oct 15, 2024 by Dow Jones
8:15AM ET on Tuesday Oct 15, 2024 by Dow JonesMeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson's Disease, from 7:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
7:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
Oct 9, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MeiraGTx Holdings PLC | 460.0M | -4.1x | --- |
C4 Therapeutics Inc | 455.3M | -3.6x | --- |
Absci Corp | 454.2M | -4.3x | --- |
ProQR Therapeutics NV | 384.4M | -12.5x | --- |
Verve Therapeutics Inc | 512.0M | -2.4x | --- |
4D Molecular Therapeutics Inc | 424.9M | -3.8x | --- |
Company Information
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.
Contact Information
- Headquarters
- 450 E 29th St Fl 15NEW YORK, NY, United States 10016-8367
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Keith Harris
- President, Chief Executive Officer, Director
- Alexandria Forbes
- Chief Financial Officer, Chief Operating Officer
- Richard Giroux
- General Counsel, Secretary
- Robert Wollin
- Chief Development Officer
- Stuart Naylor
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $460.0M |
|---|---|
Revenue (TTM) | $8.1M |
Shares Outstanding | 77.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.20 |
EPS | $-1.49 |
Book Value | $2.17 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | 56.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,083.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
